enVVeno Competitors and Similar CompaniesClear all
Kymab's competitors and similar companies include Oncoinvent and Histocell.
 Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. | ||
Founding Date | Founding Date 2009 | Founding Date 2010 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ | Locations Oslo, NO HQ | Locations Derio, ES HQ Larrabetzu, ES |
Employees | Employees 407% decrease | Employees 442% decrease | Employees 365% decrease |
Funding | |||
Latest funding round | Latest funding round $ 100m (over 9 years ago) | Latest funding round $ 4m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 220.4m | Total funding raised $ 29m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Oncoinvent
HQ
Oslo, NO
Employees
44↓ 2% decrease
Oncoinvent AS is a privately held Norwegian company established in 2010.
View companyHistocell
HQ
Derio, ES
Employees
36↓ 5% decrease
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View company